MCAS
Secret autopilot software implicated in the Boeing 737 Max crashes.
First Mentioned
9/27/2026, 4:54:26 AM
Last Updated
9/27/2026, 4:55:52 AM
Research Retrieved
9/27/2026, 4:55:52 AM
Summary
MCAS (Maneuvering Characteristics Augmentation System) is an automated flight-stabilizing software system developed for aircraft, most notably integrated into the Boeing 737 Max. Flaws within the MCAS software contributed to catastrophic crashes and the subsequent worldwide grounding of the aircraft. In a presentation analyzing institutional and technical failures, Bill Gurley highlighted how competitive pressure from Airbus led Boeing to rush the 737 Max with compromised MCAS software, while subsequent investigations revealed regulatory capture involving the FAA. Beyond aviation, the acronym MCAS in technology also denotes other systems such as Microsoft Cloud App Security and Maritime Collision Avoidance Systems.
Referenced in 1 Document
Research Data
Extracted Attributes
Primary Category
Flight Control Software / Avionics
Primary Developer
Boeing
Associated Aircraft
Boeing 737 Max
Full Name (Aviation)
Maneuvering Characteristics Augmentation System
Regulatory Body Involved
Federal Aviation Administration (FAA)
Alternative Meaning (Maritime)
Maritime Collision Avoidance System
Alternative Meaning (Cloud Computing)
Microsoft Cloud App Security (developed by Adallom)
Wikipedia
View on WikipediaMCAS
MCAS may refer to: Maneuvering Characteristics Augmentation System, an airplane flight stabilizing feature Marine Corps Air Station, a designation of multiple installations of the United States Marine Corps Maritime Collision Avoidance System Massachusetts Comprehensive Assessment System, a standards-based education assessment system Mast cell activation syndrome, an immunological disorder Matrícula Consular or Matricula Consular de Alta Seguridad, an identification card issued by the Government of Mexico Michigan City Area Schools a school district in Michigan City, Indiana Microsoft Cloud App Security, a cloud security product by Adallom Multnomah Community Ability Scale, a standardized mental health assessment
Web Search Results
- Mast Cell Activation Syndrome (MCAS)
Mast cell activation syndrome (MCAS) is a rare condition caused by overactive mast cells, leading to repeated severe symptoms.
- Mast cell activation syndrome - Insights
Mast cell activation syndrome (MCAS) is a rare, multisystem disorder characterized by an aberrant activation of mast cells that triggers them to excessively
- What is Mast Cell Activation Syndrome (MCAS)? - Allergy & Asthma Network
A doctor wearing a white coat and glasses uses a stethoscope to listen to the heartbeat of a smiling woman sitting in an examination room. The woman is wearing a light blue shirt. Mast cell activation syndrome (MCAS) is a type of mast cell disease or disorder. It occurs when mast cells are too active in your body. MCAS is considered a rare disease. Everyone has mast cells. They are a type of white blood cell involved in the body’s immune system. They help your body fight off infections and help with the healing process. Mast cells do this by releasing chemical mediators, including histamine. [...] ## At a Glance: Mast Cell Activation Syndrome Overactive cells: MCAS is a condition in which mast cells become overactive where mast cells become overactive, frequently releasing chemicals like histamine in response to triggers. Wide-ranging symptoms: Symptoms are broad and impact multiple organ systems, often including skin rashes, nausea, abdominal pain, rapid heart rate, and shortness of breath. Anaphylaxis risk: A major concern for those with MCAS is the risk of life-threatening anaphylaxis, for which epinephrine is the essential first-line treatment. Common triggers: Activation can be triggered by temperature changes, allergens (like pollen), certain medications, foods, and alcohol. [...] You may have specific questions about MCAS. Here’s a Q&A with some common questions about this syndrome. If there’s another question about MCAS you’d like to see answered, please email the editor. Mast cell activation syndrome and mastocytosis are disorders involving mast cells. They can cause similar symptoms after the release of mast cell chemical mediators. Both can lead to anaphylaxis. But these are also two distinct conditions. MCAS involves mast cells that are overly reactive when they release chemical mediators such as histamine. It is diagnosed when there are severe reactions involving multiple body organs.
- Mast Cell Activation Syndrome (MCAS)
MCAS is a condition in which the patient experiences repeated episodes of the symptoms of anaphylaxis – allergic symptoms such as hives, swelling, low blood pressure, difficulty breathing and severe diarrhea. High levels of mast cell mediators are released during those episodes. The episodes respond to treatment with inhibitors or blockers of mast cell mediators. The episodes are called “idiopathic” which means that the mechanism is unknown - that is, not caused by allergic antibody or secondary to other known conditions that activate normal mast cells. Low grade chronic mast cell mediator release may also cause symptoms that do not reach the level of anaphylaxis. [...] Mast cells are allergy cells responsible for immediate allergic reactions. They cause allergic symptoms by releasing products called “mediators” stored inside them or made by them. In allergic reactions, this release occurs when the allergy antibody IgE-Defined), which is present on the mast cell surfaces, binds to proteins that cause allergies, called allergens. This triggering is called activation, and the release of these mediators is called degranulation. [...] Mast cells are known to produce many molecules that cause inflammation, but only a few mediators or their stable breakdown products (metabolites) have been found reliably elevated in episodes of MCAS and measurable in commercial laboratory tests. Increases in serum mast cell tryptase and in urine levels of N-methylhistamine, 11B -Prostaglandin F2α (11B-PGF2α) and/or Leukotriene E4 (LTE4) are the only useful tests in diagnosis of MCAS. Total serum mast cell tryptase should be drawn between 30 minutes and two hours after the start of an episode, with baseline level obtained many days later. The urine tests are performed on spot urine samples or 24 hour collections that are started immediately.
- Information about Mast Cell Activation Syndrome, MCAS
Logo: Mast Cell ActionMini Logo: Mast Cell Action Pictures of MCAS volunteers and fundraisers in bubbles across a header saying 'About MCAS' A women living with MCAS in the snow, wearing a hat ### What is Mast Cell Activation Syndrome? Mast Cell Activation Syndrome (MCAS) is a condition which can develop in children or adults. MCAS forms part of a spectrum of mast cell disorders. People with MCAS may also have other mast cell disorders such as mastocytosis or hereditary alpha tryptasemia syndrome (HATS). [...] In people affected by MCAS, chemicals called mast cell mediators are released too frequently or abundantly, and/or in response to triggers that are not typically considered to be harmful, for example; foods or chemicals in the environment. This can lead to a wide range of symptoms that affect multiple parts of the body. Triggers and symptoms of MCAS vary greatly between individuals. Triggers can include fragrances, exercise, stress and changes in temperature. MCAS symptoms can come and go and may often change over time within the same person. This can make it difficult to identify specific triggers, and the number of triggers and severity of symptoms may continue to increase as the condition progresses. [...] A blood test to evaluate tryptase levels is often performed, particularly as it is a strong marker for mastocytosis and for HATs, but it is considered less specific for MCAS as many people affected by MCAS do not have high baseline tryptase levels. This means that their normal, everyday tryptase levels are not high. They may however be higher during a symptom flare or during anaphylaxis, but it can be challenging to obtain blood samples at this precise time for testing. Other mast-cell mediators can be tested for with a 24-hour urine collection. These include methylhistamine and prostaglandins. Elevated results of these can be suggestive of MCAS but having normal levels doesn’t rule out MCAS and repeated testing may be needed.
Wikidata
View on WikidataInstance Of
DBPedia
View on DBPediaLocation Data
MCAS Miramar Airfield, Johnson Road, San Diego, San Diego County, California, 92137, United States
Coordinates: 32.8711742, -117.1387554
Open Map